XML 87 R73.htm IDEA: XBRL DOCUMENT v3.20.4
Investment in Loans (Schedule of 90 Days or More Past Due) (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance $ 1,417,054 $ 1,387,733
Loans, at fair value [1],[2] 1,453,480 1,412,426
Proceeds from the disposition of loans (non-cash) 113,791 0
Commercial mortgage loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 212,716 277,870
Loans, at fair value 213,031 274,759
Residential mortgage loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 1,150,303 911,705
Loans, at fair value 1,187,069 932,203
Consumer loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 48,180 179,743
Loans, at fair value 47,525 186,954
Non-accrual status [Member] | Commercial mortgage loans    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Loans, at fair value   10,700
Non-accrual status [Member] | Commercial mortgage loans | 90 Days or More Past Due [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 44,233 28,936
Loans, at fair value 44,052 26,545
Non-accrual status [Member] | Residential mortgage loans | 90 Days or More Past Due [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 64,509 22,092
Loans, at fair value 60,381 19,401
Non-accrual status [Member] | Consumer loans | 90 Days or More Past Due [Member]    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Unpaid Principal Balance 1,015 5,633
Loans, at fair value $ 930 $ 5,225
[1] Ellington Financial Inc.'s Consolidated Balance Sheet includes assets and liabilities of variable interest entities it has consolidated. See Note 9 for additional details on Ellington Financial Inc.'s consolidated variable interest entities.
[2] Includes assets pledged as collateral to counterparties. See Note 11 for additional details on the Company's borrowings and related collateral.